stage III adenoid cystic carcinoma of the oral cavity
Showing 1 - 25 of >10,000
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,
Not yet recruiting
- Adenoid Cystic Carcinoma
- +2 more
- CB-103
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 14, 2023
Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma
Completed
- Recurrent Oral Cavity Adenoid Cystic Carcinoma
- +11 more
- Laboratory Biomarker Analysis
- Vorinostat
-
Duarte, California
- +11 more
Jul 14, 2020
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IVA
Withdrawn
- Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
- +6 more
- hypofractionated radiation therapy
- +3 more
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- +4 more
- Near Infrared Imaging
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 5, 2022
Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication
Completed
- Caregiver
- +37 more
- Communication Intervention
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 14, 2022
Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous
Recruiting
- Oral Cavity Squamous Cell Carcinoma
-
Guangzhou, Guangdong, ChinaLiuxiqiang
Feb 1, 2023
Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)
Not yet recruiting
- Squamous Cell Carcinoma
- Oral Cavity Squamous Cell Carcinoma
- Tiragolumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced
Recruiting
- Head and Neck Carcinoma of Unknown Primary
- +24 more
- Cisplatin
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 6, 2022
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV
Recruiting
- Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +28 more
- Cisplatin
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 16, 2022
Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal
Not yet recruiting
- Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
- +15 more
- Best Practice
- +9 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Aug 23, 2022
Stage I Oral Cavity Squamous Cell Carcinoma, Stage II Oral Cavity Squamous Cell Carcinoma Trial in Buffalo, Rochester (drug,
Terminated
- Stage I Oral Cavity Squamous Cell Carcinoma
- Stage II Oral Cavity Squamous Cell Carcinoma
- HPPH
- +4 more
-
Buffalo, New York
- +1 more
May 6, 2022
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Biospecimen Collection
- +9 more
- (no location specified)
Oct 10, 2023
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous
Suspended
- Advanced Head and Neck Squamous Cell Carcinoma
- +17 more
- Intensity-Modulated Radiation Therapy
- Peposertib
-
Gilbert, Arizona
- +19 more
Dec 31, 2022
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +24 more
- Carboplatin
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 18, 2022
Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell
Active, not recruiting
- Head and Neck Carcinoma of Unknown Primary
- +19 more
- Berzosertib
- +3 more
-
Duarte, California
- +18 more
Aug 24, 2022
Melanoma (Skin), Squamous Cell Carcinoma of the Skin, Carcinoma, Squamous Cell of Head and Neck Trial in Worldwide (CV8102,
Active, not recruiting
- Melanoma (Skin)
- +3 more
- CV8102
- CV8102 + anti-PD-1 therapy
-
Graz, Austria
- +21 more
Nov 3, 2021
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,
Not yet recruiting
- Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +10 more
- Carboplatin
- +9 more
- (no location specified)
Jan 31, 2023
Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma, Gingival Squamous Cell Carcinoma Trial in Canada,
Recruiting
- Buccal Mucosa Squamous Cell Carcinoma
- +11 more
- Computed Tomography (CT)
- +5 more
-
Tucson, Arizona
- +71 more
Jan 11, 2023
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Laboratory Biomarker Analysis
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2022
Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)
Suspended
- Brenner Tumor
- +27 more
- metformin hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
May 16, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +26 more
- Biopsy
- +5 more
-
Newark, Delaware
- +52 more
Feb 2, 2023
Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in
Recruiting
- Advanced Pancreatic Carcinoma
- +27 more
- Biopsy
- Talazoparib
-
Gainesville, Florida
- +3 more
Jan 3, 2023
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021